Celgene Revamps IO Deal With Emerging Biotech Sutro; Takeover Option Removed

 
• By Lucie Ellis-Taitt
Businessman comparing two documents, neutral background
Celgene and Sutro redraft 2014 immuno-oncology deal • Source: Shutterstock

More from Deals

More from Business